The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.
نویسندگان
چکیده
Isoniazid, the hydrazide of isonicotinic acid, was synthesized for the first time in 1912 by two Czech scientists, but its powerful antituberculous activity was detected only in 1951, and the discovery of isoniazid was a milestone in the chemotherapy of tuberculosis. Its activity is excellent against species of the Mycobacterium tuberculosis complex (M. tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG and Mycobacterium africanum), but it shows no or very little activity against non-tuberculous mycobacteria. The mode of action of isoniazid has been the subject of intensive studies, and beyond pleiotropic effects like the inhibition of protein and nucleic acid synthesis, the most constant finding was the loss of acid-fastness of the tubercle bacilli probably as a result of the inhibition of the synthesis of mycolic acids, the long-chained, branched fatty acids found in the cell wall. As these are confined essentially to the mycobacteria they represent a selective target for antimycobacterial drugs. Another hypothesis on the mode of action of isoniazid, originating from the chemical structure of isoniazid which is very similar to that of nicotinamide, aimed at the metabolism of nicotinamide adenine dinucleotide (NAD) which is an important cofactor of many enzyme systems in the bacterial cell. It was observed that isoniazid induced an activation of the mycobacterial NADase, followed by a diminution of the intracellular NAD concentration which could explain the pleiotropic effects on the mycobacterial cell by isoniazid. Nevertheless, this hypothesis did not allow an explanation of resistance to isoniazid, as the effects on NAD were identical in isoniazid susceptible and resistant strains of M. tuberculosis.
منابع مشابه
تشخیص موتاسیون در کدون 315 ژن katG، مارکر مقاومت به ایزونیازید در سوشهای مایکوباکتریوم توبرکولوزیس جدا شده از بیماران اصفهان و تهران با روش PCR-RFLP
Background and Objective: Drug resistance to tuberculosis is continuously increasing and is a significant threat to tuberculosis control programs because afew effective drugs are present against Mycobacterium tuberculosis. Although isoniazid (INH) is the most effective drug against tuberculosis, resistance to this drug also develops readily. Mutations in katG, specially the Ser315Thr substituti...
متن کاملVirulence in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India
Isoniazid, is the only antituberculous drug for which the relation between lack of virulence and acquisition of resistance was associated. INH-resistant mutants were shown to contain defective katG gene. Classical studies showed that INH-resistant south Indian isolates have lower virulence in guinea pigs and higher susceptibility to H2O2. It is of interest to assess the virulence in south India...
متن کاملDetection of Isoniazid-Resistant Clinical isolates of Mycobacterium tuberculosis from India using Ser315Thr marker by Comparison of molecular methods
In this study, Substitution at codon Ser315 of katG gene, a reliable marker for isoniazid (INH) resistance was analyzed and compared by three molecular methods such as DNA sequencing, polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and PCR-single strand conformation polymorphism (PCR-SSCP) in 105 phenotypically resistant isolates obtained from various parts of Ind...
متن کاملMinor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
متن کامل
Isoniazid MIC and KatG Gene Mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran
Objective(s) Isoniazid (INH) is one of the main first line drugs used in treatment of tuberculosis and development of resistance against this compound can result in serious problems in treatment procedures. Resistance to INH is mediated mainly by mutation in KatG gene that is coded for the catalase enzyme. The proportional method for detection of INH-resistance is time consuming due to the slo...
متن کاملEvaluating the effect of Dracocephalum kotschyi methanol extract on Mycobacterium tuberculosis
Background and objectives: Tuberculosis (TB) is the major public health problem in the world. Each year there are 2-3 million deaths worldwide caused by TB. The increasing incidence of Multi Drug Resistance tuberculosis (MDR-TB) worldwide highlights the urgent need to search for new anti-tuberculosis compounds. It has been reported that medicinal plant, Dracocephalum kotschyi, possesse...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
دوره 79 4 شماره
صفحات -
تاریخ انتشار 1999